Skip to main content
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.950
-0.320 (-7.49%)
At close: Apr 28, 2026, 4:00 PM EDT
3.930
-0.020 (-0.51%)
After-hours: Apr 28, 2026, 8:00 PM EDT

Perspective Therapeutics Revenue

In the year 2025, Perspective Therapeutics had annual revenue of $884.00K, down -39.20%. Perspective Therapeutics had revenue of $43.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$884.00K
Revenue Growth
-39.20%
P/S Ratio
509.47
Revenue / Employee
$5,325
Employees
166
Market Cap
450.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025884.00K-570.00K-39.20%
Dec 31, 20241.45M20.00K1.39%
Dec 31, 20231.43M-3.98M-73.52%
Dec 31, 20225.42M--
Jun 30, 2022---
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 854.40M
Orthofix Medical 822.31M
Tactile Systems Technology 329.52M
OrthoPediatrics 236.35M
Cerus 206.13M
Cytek Biosciences 201.49M
SI-BONE 200.93M
Pacific Biosciences of California 160.01M
Revenue Rankings

CATX News

More News